Lidocaine 4% Plus Menthol 1% Topical Anesthetic Pain Cream
NDC Package 73715-006-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidocaine 4% Plus Menthol 1% Topical Anesthetic Pain Cream (lidocaine 4% plus menthol 1% pain cream) cream is • Adults and children 2 years and older: apply externally to the affected area up to 3-4 times a day. This formulation utilizes a cream delivery system. Marketed by Mohnark Pharmaceuticals Inc, this product is identified by NDC 73715-006 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
73715-006-01
Package Description
30 g in 1 TUBE
Product Code
73715-006
11-Digit Billing Format
73715000601

Clinical Specifications

Proprietary Name
Lidocaine 4% Plus Menthol 1% Topical Anesthetic Pain Cream
Non-Proprietary Name
Lidocaine 4% Plus Menthol 1% Pain Cream
Substance Name
Lidocaine; Menthol
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
• Adults and children 2 years and older: apply externally to the affected area up to 3-4 times a day. • Children under 2 years of age: consult a doctor.

Regulatory & Marketing

Labeler Name
Mohnark Pharmaceuticals Inc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73715-006-01 identifies a specific commercial package of 30 g in 1 tube of Lidocaine 4% Plus Menthol 1% Topical Anesthetic Pain Cream, a human over the counter drug labeled by Mohnark Pharmaceuticals Inc. This cream is formulated for topical use and contains lidocaine; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mohnark Pharmaceuticals Inc on July 01, 2025. The current certification is valid through December 31, 2026.

How is this Mohnark Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73715000601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73715-006-01
11-Digit CMS (5-4-2)
73715-0006-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.